<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03159923</url>
  </required_header>
  <id_info>
    <org_study_id>35RC16_8919_TRAP</org_study_id>
    <nct_id>NCT03159923</nct_id>
  </id_info>
  <brief_title>Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation</brief_title>
  <acronym>TRAP</acronym>
  <official_title>Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to improve the definition of the two main types of secondary
      tricuspid regurgitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2017</start_date>
  <completion_date type="Anticipated">January 19, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 19, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite criteria : cardiovascular death or unscheduled hospitalizations due to cardiovascular event.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Remodeling, Cardiac</condition>
  <condition>Tricuspid Regurgitation</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate to severe tricuspid regurgitation (≥ 2/4) diagnosed with echocardiography in patients stabilized.</intervention_name>
    <description>Moderate to severe tricuspid regurgitation (≥ 2/4) diagnosed with echocardiography in patients stabilized.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with moderate to severe tricuspid regurgitation (≥ 2/4) diagnosed with
        echocardiography, in patients stabilized.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patients ≥ 18 years old, with moderate to severe tricuspid regurgitation (≥ 2/4),
             agreeing to participate ;

          -  The patients included can be ambulatory patients or stabilized hospitalised patients
             (meaning patient clinicaly stable, not decompensated, and whose normovolemia has been
             checked).

          -  Non opposition of the patient

        Exclusion Criteria:

          -  Patient whose accoustic window is judged by the operator as incompatible with a
             precise evaluation of the tricuspid regurgitation or anatomy of the right cavity ;

          -  TR &lt; grade 2 ;

          -  TR secondary to primary pulmonary hypertension or congenital cardiopathy ;

          -  Primary tricuspid regurgitation (due to rheumatic heart disease, medication - included
             benfluorex, due to endocarditis, valvular prolapse, carcinoid syndrom or a cardiac
             stimulation lead …) ;

          -  Significant left heart valvulopathy (Mitral regurgitation &gt; grade 2, Aortic
             insufficiency &gt; grade 2, Mitral stenosis &lt; 2 cm², Aortic stenosis &lt; 1.5 cm²). A
             valvulopathy sucessfully operated isn't considered as an exclusion criteria;

          -  Cardiopathy with significative systolic dysfunction (FE&lt; 40%) ;

          -  Patients whose life expectantcy is less than 1 year due to a pathology independent of
             the TR (neoplasic process for example) ;

          -  Patient under judicial protection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erwan DONAL, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristell COAT</last_name>
    <phone>2 99 28 25 55</phone>
    <phone_ext>+33</phone_ext>
    <email>kristell.coat@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Direction de la Recherche</last_name>
    <phone>2 99 28 25 55</phone>
    <phone_ext>+33</phone_ext>
    <email>drc@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Amiens-Picardie - Site Sud</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe TRIBOUILLOY, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Christophe TRIBOUILLOY, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ap-Hp - Hopital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien TERNACLE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Julien TERNACLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de DIJON - HOPITAL FRANCOIS MITTERAND</name>
      <address>
        <city>Dijon</city>
        <zip>21034</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe EICHER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Christophe EICHER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Grenoble - Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles BARONE-ROCHETTE, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Gilles BARONE-ROCHETTE, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ghicl - Hopital Saint Philibert</name>
      <address>
        <city>Lomme</city>
        <zip>59462</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvestre MARECHAUX, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sylvestre MARECHAUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Marseille - Hopital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck THUNY, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Franck THUNY, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Joseph</name>
      <address>
        <city>Marseille</city>
        <zip>13285</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud MAUDIERE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Arnaud MAUDIERE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Du Pont de Chaume</name>
      <address>
        <city>Montauban</city>
        <zip>82000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier BRUERE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Didier BRUERE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CLINIQUE du MILLENAIRE</name>
      <address>
        <city>Montpellier</city>
        <zip>34960</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine SPORTOUCH-DUKHAN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine SPORTOUCH-DUKHAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu de Nancy - Hopital de Brabois</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine SELTON-SUTY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christine SELTON-SUTY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de NANTES - HOTEL DIEU</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry LE TOURNEAU, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Thierry Mr LE TOURNEAU, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ap-Hp - Hopital Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephane EDERHY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Stephane EDERHY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu de Bordeaux - Groupe Hospitalier Sud</name>
      <address>
        <city>Pessac</city>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stéphane LAFITTE, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Patricia REANT, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Stéphane LAFITTE, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia REANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erwan DONAL, PhD</last_name>
      <phone>2 99 28 94 75</phone>
      <phone_ext>+33</phone_ext>
      <email>erwan.donal@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Erwan Mr DONAL, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de TOULOUSE - HOPITAL RANGUEIL</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier LAIREZ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier LAIREZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique NCT+</name>
      <address>
        <city>Tours</city>
        <zip>37042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clémence ANTOINE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Clémence ANTOINE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de TOURS - HOPITAL TROUSSEAU</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne BERNARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne BERNARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

